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ABSTRACT
Histone chaperones are proteins that interact with hi-
stones to regulate the thermodynamic process of nu-
cleosome assembly. sNASP and ASF1 are conserved
histone chaperones that interact with histones H3
and H4 and are found in a multi-chaperoning com-
plex in vivo. Previously we identified a short pep-
tide motif within H3 that binds to the TPR domain
of sNASP with nanomolar affinity. Interestingly, this
peptide motif is sequestered within the known ASF1–
H3–H4 interface, raising the question of how these
two proteins are found in complex together with his-
tones when they share the same binding site. Here,
we show that sNASP contains at least two additional
histone interaction sites that, unlike the TPR–H3 pep-
tide interaction, are compatible with ASF1A binding.
These surfaces allow ASF1A to form a quaternary
complex with both sNASP and H3–H4. Furthermore,
we demonstrate that sNASP makes a specific com-
plex with H3 on its own in vitro, but not with H4,
suggesting that it could work upstream of ASF1A.
Further, we show that sNASP and ASF1A are capa-
ble of folding an H3–H4 dimer in vitro under native
conditions. These findings reveal a network of bind-
ing events that may promote the entry of histones H3
and H4 into the nucleosome assembly pathway.
INTRODUCTION
Histone chaperones are defined as proteins that contribute
to the thermodynamic assembly of nucleosomeswithout be-
ing part of the final product. Histone chaperones adopt nu-
merous proteins folds, often containing multiple domains
and can exist in multi-subunit complexes (1). Many of these
interactions have been elucidated at the structural and bio-
chemical level, revealing a highly diverse repertoire of hi-
stone interaction modules (2,3). Understanding how these
interactions function together in multi-protein complexes is
crucial for a better understanding of the process of nucleo-
some assembly.
With regards to histone chaperones specific to H3–H4, a
series of crystal structures has demonstrated how this speci-
ficity is achieved, supporting the concept of ‘histone hand-
off’ between chaperoning complexes proposed from previ-
ous biochemical analysis of histone chaperone interactions
(2,4). For example, the unique specificity of the HIRA com-
plex for histoneH3.3 is mediated through the recognition of
three residues unique toH3.3 byUBN1 (5). The binding site
occupied by UBN1 is not compatible with the structure of
the chaperone DAXX in complex with H3.3–H4 (6), in sup-
port of previous findings showing that the DAXX-ATRX
and HIRA form two discrete complexes in the cell (7,8).
Similarly, the histone chaperone ASF1 was shown through
biochemical analysis to bind to histones H3–H4 concomi-
tantly with the MCM helicase complex (9–11), a finding
supported by recent crystal structures of the ASF1–H3–
H4–MCM2 co-chaperoning complex (12,13). These ter-
tiary and quaternary complexes are thought to represent
snapshots of dynamic ‘histone hand-off’ mechanisms dur-
ing histone folding and chromatin maturation.
The human chaperone NASP represents a unique fam-
ily of TPR motif containing proteins that interact specif-
ically with histones H3–H4 (14–16). In the cell, NASP
is found in a multi-subunit complex containing the co-
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chaperones RbAp46 and ASF1A and the histone acetyl-
transferase HAT1, amongst other components (8,10,11,17–
22). This interaction network is highly conserved, occurring
in evolutionary distant organisms such as the budding yeast
Saccharomyces cerevisiae (17,23) and the ciliated protozoan
Tetrahymena thermophila (24). We recently demonstrated
that the TPR domain of sNASP (the somatic splice isoform
of humanNASP) binds to a discreteH3 peptidemotif found
within the globular core of the H3–H4 dimer with nanomo-
lar affinity (25). Interestingly, whilst the NASP epitope is
distinct from the interaction site of RbAp46 andHAT1 (26–
29), the interaction site overlaps significantly with that of
ASF1 (30–32). This raised the question of how two histone
chaperones are found in complex with each other when they
share the same binding site for their histone substrate.
In order to reconcile these findings, we undertook a
comprehensive interaction analysis between sNASP and
ASF1A and their histone cargo. Using in vitro biochem-
ical reconstitution assays we confirmed that sNASP and
ASF1A do indeed compete for the C-terminal epitope of
H3, with sNASP outcompeting ASF1A, and also discov-
ered that sNASP forms a stable complexwith full lengthH3,
but not with H4. Interaction analysis with an H3–H4 dimer
revealed that both sNASP andASF1A can interact with the
same dimer at the same time, and that sNASP contributes to
the solubility of the hetero-tetrameric complex under phys-
iological conditions. Importantly, using a cellular interac-
tion assay we show that ASF1A outcompetes sNASP at the
C-terminus of H3 when bound to the H3–H4 dimer, as is
suggested by the crystal structure of ASF1 (30), and pro-
pose that additional interactions between sNASP and H3–
H4 must exist to retain sNASP within the sNASP–H3–H4–
ASF1A complex. To investigate this further we generated
two site-specific monobodies against sNASP that revealed
additional interaction sites involving the central acidic do-
main that interrupts the TPR2 motif, and one other site on
the TPR domain that lies outside of the central H3 peptide-
binding channel. Interestingly, these additional interaction
sites were occupied both when sNASP was in complex with
H3 alone and when sNASP was in complex with an H3–H4
dimer, suggesting that sNASP may hold H3 in a conforma-
tion that is conducive to folding with H4. To test this hy-
pothesis, we carried out in vitro folding reactions and found
that sNASP and ASF1A are capable of producing a folded
H3–H4 dimer from monomeric subunits under physiolog-
ical conditions, and that precomplexation of sNASP with
histones before the addition of ASF1A was necessary for
efficient folding to occur. Our findings reveal a dynamic
interplay between two conserved histone chaperones, and
suggests an intricate network of histone binding events that
contribute to efficient H3–H4 folding and entry into the hi-
stone deposition pathway.
MATERIALS AND METHODS
Protein expression and purification
sNASP was expressed in bacteria as an N-terminal (His)6
fusion construct using Ni-NTA affinity resin (GE Health-
care) and was further purified by ion-exchange and gel fil-
tration chromatography after cleavage of the (His)6 fusion
by TEV protease, as described previously (25). sNASP mu-
tants, truncations and the budding yeast homologHif1 were
expressed and purified using the same method. N-terminal
tagged GST-ASF1A was expressed in bacteria and puri-
fied over a Glutathione Sepharose resin (GE Healthcare),
the GST tagged removed with Precision Protease cleav-
age, and further purified using anion exchange and gel fil-
tration chromatography. Mb13 was expressed as a (His)6,
Avitag fusion in bacteria, and after cleavage of the (His)6
fusion, was further purified by ion exchange and size ex-
clusion chromatography. Full length Xenopus histones H3
and H4 were purified and refolded as described previously
to form the H3–H4 dimer/tetramer (33). For reconstitution
of monomeric histones with chaperones, H3 and H4 were
dialyzed to water and then added directly to the chaperone.
MBP–H3 (116–135) and MBP-mb1 were expressed in the
same way as sNASP and purified over Dextrin Sepharose
(GE Healthcare) in 20 mM HEPES–KOH pH 7.5 and 0.5
M sodium chloride, eluted in the same buffer supplemented
with 10mMmaltose.Maltose was removed by dialysis prior
to storage at –80◦C.
Analytical gel filtration
Analytical gel filtration was carried out using either a Su-
perdex S200 10/300 GL column, or later a Superdex 200
Increase 10/300 GL column (GE Healthcare), in 20 mM
HEPES–KOH pH 7.5 and 200 mM sodium chloride, unless
otherwise stated in the text. Samples were made up in the
same buffer containing 5 mM dithiothreitol prior to sep-
aration. Typically, 0.5 l fractions were collected encom-
passing the void and bed volumes of the column. Fractions
were separated by SDS-PAGE and stained with Coomassie
Brilliant Blue (SERVA). Proteins and complexes were re-
constituted at a concentration of 20 M, unless other-
wise stated in the text, before separating out by gel filtra-
tion chromatography. For sNASP N330 and sNASP cTPR,
the sNASP mutants were added to equimolar amounts of
ASF1A–H3–H4 in 20 mM HEPES–KOH pH 7.5 and 500
mM NaCl. The higher salt concentration was used to pre-
vent potential precipitation of the ASF1A–H3–H4 complex
in the absence of sNASP binding. Gel filtration was then
carried out as above in 20 mM HEPES–KOH pH 7.5 and
200 mM sodium chloride.
Solubilization of ASF1A-H3–H4 through salt titration, or by
sNASP
For the salt titration, ASF1A was mixed with H3–H4
dimers at 20 M each in a volume of 50 l containing
20 mM HEPES–KOH pH 7.5 and 0.2 M sodium chlo-
ride, resulting in near complete precipitation of the com-
plex. Sodium chloride was then titrated to the concentra-
tions shown in Figure 2A. Samples were incubated for 30
min at 30◦C, before separating soluble and precipitated ma-
terial by centrifugation. The precipitate was lightly washed
with 50 l of the same buffer to remove residual soluble
protein. Insoluble proteins were solubilized by addition of
2× SDS-PAGE loading buffer and equal volumes of insolu-
ble and soluble material were separated by SDS-PAGE. For
the sNASP titration (Figure 2B), ASF1A and H3–H4 were
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made up as before, but increasing concentrations of sNASP
were titrated into the precipitate whilst keeping the sodium
chloride concentration constant.
Fluorescence-2-hybrid assay
For analysis of protein–protein interactions using the F2H
assay we used a human U2OS cell line harbouring the sta-
bly integrated LacO (256×) array, as has been described
earlier (34). F2H assays were essentially performed as pre-
viously described in (35,36) and (25,34). U2OS cells were
cultured in DMEM containing 10% FBS (GIBCO), 2 mM
L-glutamine (Sigma), 100 U ml−1 penicillin, 100 g ml−1
streptomycin (Sigma) in a humidified atmosphere with 5%
CO2 at 37◦C. Transient transfections of cells seeded onto
an eight-well -Slide (ibidi) were carried out using Xfect
(Clonetech) according tomanufacturers instructions. Imag-
ing was carried out on a Zeiss AxioObserver Z1 confo-
cal spinning disk microscope equipped with an AxioCam
HRm CCD camera (Zeiss) through a Zeiss C-Apochromat
40×/1.2 water immersion objective lens. Image analysis was
manually performed with ImageJ image analysis software.
Fluorescence intensity at the LacI array was calculated as a
percentage increase over the nucleoplasm. Briefly, a region
of interest (ROI) was drawn around the LacO array as de-
marcated by the LacI-mCherry fusion protein. The average
intensity of the fluorescence from the ROI was then com-
pared to the average intensity from a same size ROI taken
from an adjacent region of the nucleus. TheWilcoxen Rank
Sum Test was used as a normal distribution could not be
assumed. Only cells in which a clearly discernable array was
present were counted. As with previous experiments (25), a
total of 20 cells were counted as not to inflate the calculated
P-value.
Selection of monobodies and affinity measurements
A phage-display library of monobodies, dubbed ‘side
libarry’ (37) was used for the selection of the sNASP-
binding monobodies using previously described methods
(37–39). A total of four rounds of phage-display library
selection were performed using the target concentrations
of 100, 100, 50 and 50 nM. The enriched pools of mono-
body clones were converted into yeast libraries after per-
forming gene shuffling among them, as described previously
(37), and two rounds of library sorting using fluorescence-
activated cell sorters were performed using the target con-
centrations of 500 and 250 nM. Affinity of the monobodies
was measured using the yeast display method as described
previously (39). We have validated using numerous mono-
bodies that the KD values measured in this manner are con-
sistent with those determined from biophysical methods us-
ing purified monobodies (39–41). Cell lysate of HEK293T
cells was prepared in the high salt buffer (10 mM Tris–HCl
pH 8, 420 mM NaCl, 0.1% NP-40) and the lysate concen-
tration was adjusted so that its OD280nm in the binding assay
was 3.0.
Analysis of monobody–sNASP interactions
Analytical gel filtration of sNASP complexes with mono-
bodies was carried out under 200 mM NaCl, 20 mM
HEPES–KOH pH 7.5 and 1 mMEDTA on a Superdex 200
10/300 GL column (GE Healthcare). 30 uM of each com-
ponent was made up in the same buffer with 2 mM DTT,
with monobodies being added first followed by sNASP, hi-
stones and then ASF1A. Peaks from the elution profiles
were separated out on SDS-PAGE gel and stained with
Coomassie Brilliant Blue (SERVA).
H3–H4 folding assay
Purified sNASP and ASF1A were dialyzed to 200 mM
sodium chloride, 20 mM HEPES–KOH pH 7.5, concen-
trated to 200 Mand supplemented with 2 mM dithiothre-
itol. Lyophilized H3 and H4 were dissolved in water at a
concentration of 200 M and supplemented with 2 mM
dithiothreitol. 5 l of each component was added to 30 l
of buffer containing 200 mM sodium chloride and 20 mM
HEPES–KOH pH 7.5, in all possible orders of addition,
to give a final volume of 50 l and final concentration of
20 M. Samples were incubated at 30◦C for 30 min before
isolating soluble and insoluble material by centrifugation.
Proteins were separated by SDS-PAGE and stained with
Coomassie Brilliant Blue (SERVA). Total relative precipi-
tation from each lane was quantified using ImageJ (http:
//imagej.net/Fiji). The maximum and minimum values were
used to normalise values from three independent experi-
ments.
H3–H4 deposition assay
Deposition of H3–H4 onto DNA was carried out in a sim-
ilar fashion as has been previously reported (42–45). A 91
base pair DNA corresponding to the central portion of the
Widom 601DNA sequence (46,47) wasmixed at a final con-
centration of 500 nM with 1, 2 or 4 M of prefolded H3–
H4 dimers, unfolded H3 and H4, sNASP–H3–H4–ASF1A
complex made from prefolded histones, or the same com-
plex made from unfolded histones, in a final volume of 20
l. The buffer composition was 20 mM HEPES–KOH pH
7.5 and 200 mMNaCl. Samples were incubated at 25◦C for
1 h, precipitates removed by centrifugation, 1 l of soluble
material was added to 10 l of 4% sucrose and resolved on
a 7% poly-acrylamide gel in 0.5% TBE buffer at 4◦C. The
gel was visualized by staining with ethidium bromide.
RESULTS
sNASP and ASF1A bind competitively to both an H3 C-
terminal peptide and to full length H3
In a screen looking for the peptide binding epitope of the
TPR domain of sNASP, we previously identified a short
motif close to the C-terminus of H3 that bound with high
affinity and specificity (25). Interestingly, residues crucial to
this interaction are sequestered in the interface between H3
and the co-chaperone ASF1 (Figure 1A and B) (30–32). We
therefore wanted to determine if sNASP and ASF1A bind
to this region competitively. Incubation of ASF1A with an
H3 peptide (incorporating residues 116–135) fused to MBP
resulted in co-elution of the two proteins in a single com-
plex as seen by coomassie staining of fractions from gel fil-
tration chromatography (Figure 1C and D), as was previ-
ously seen with a similar H3 peptide (31). This is shown
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Figure 1. sNASP andASF1A bind competitively to histoneH3. (A) Crystal structure of ASF1A bound to anH3–H4 dimer (PDB code: 2IO5) with residues
from the previously mapped sNASP binding site (25) shown as yellow spheres. (B) Detailed view of H3 residues involved in binding the TPR domain of
sNASP in complex with ASF1A. (C) Gel filtration elution profile of free MBP H3 (116–135). (D) Gel filtration elution profile of ASF1A bound to MBP
H3 116–135 (ASF1A was kept at a molar excess over the MBP H3 (116–135) peptide to visualise both free and bound ASF1A). (E) Elution profile of
equimolar amounts of sNASP, ASF1A andMBP H3 116–135, revealing that sNASP can effectively outcompete ASF1A for binding to the H3 C-terminal
peptide. (F) Elution profile of sNASP complexed with full-length histone H3. (G) Elution profile of sNASP, ASF1A and full-length H3. ASF1A is unable
to bind to H3 whilst it is associated with sNASP, eluting in its unbound fraction.
by the shifting of the MBP–H3 116–135 and ASF1A peak
to earlier eluting fractions when compared to their elution
alone (for ASF1A elution see Figure 1E and G). We next
wanted to know whether sNASP effectively competed with
ASF1A for H3 peptide binding. Mixing equimolar concen-
trations of MBP–H3 (116–135), ASF1A and sNASP and
separating out the complexes by gel filtration chromatog-
raphy, we found that the MBP–H3 (116–135) peptide co-
eluted with sNASP rather than ASF1A (Figure 1E), sug-
gesting that with respect to the very C-terminus of H3,
sNASP and ASF1A bind competitively, with sNASP out-
competing ASF1A.
Next, we wanted to know whether sNASP and ASF1A
binding are mutually exclusive with regard to the full-length
H3 protein. Histones are notoriously aggregation-prone in
the absence of their folding partner. We found, however,
that sNASP formed a stable, soluble complex withH3 in the
absence of H4 (Figure 1F). Interestingly, whilst soluble on
their own, H3 andASF1A formed a precipitate whenmixed
in stoichiometric amounts (Supplementary Figure S1A).
Crucially, addition of sNASP to this precipitate resulted in
solubilization of both proteins, with sNASP and H3 coelut-
ing in a single complex and ASF1A eluting on its own when
analyzed by gel filtration chromatography (Figure 1G). In
addition to H3, we also tested for potential interaction be-
tween sNASP and histone H4.We found that while remain-
ing soluble, themajority of histoneH4 formed a highmolec-
ular weight aggregate with sNASP, which eluted in the void
volume of the column (Supplementary Figure S1B). These
experiments demonstrate that ASF1A and sNASP compete
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for binding to the C-terminal region of H3, in agreement
with previous structural and biochemical analysis of these
chaperones (25,30), and that sNASP forms a soluble com-
plex with full length H3 that excludes ASF1A binding.
sNASP and ASF1A bind compatibly to an H3–H4 dimer
Although a complex containing sNASP and ASF1A has
been extensively studied previously, the majority of these
studies have focused on chaperoning complexes isolated
from cultured cells, where a number of other components
were present (8,11,15–21). To determine if sNASP and
ASF1A can form a complex with H3–H4 in the absence of
other factors, we attempted an in vitro reconstitution using
purified chaperones and an H3–H4 dimer. As the complex
formed between ASF1A and H3–H4 is prone to precipita-
tion under physiological salt concentrations (30,32,48) (Fig-
ure 2A), we initially attempted to reconstitute complexes in
high salt buffers (0.6M sodium chloride or higher). This at-
tempt failed, as sNASP did not associate with ASF1–H3–
H4 under the conditions needed for ASF1–H3–H4 solubil-
ity. Interestingly, however, we noticed that titrating sNASP
into a precipitated ASF1–H3–H4 complex resulted in the
same solubilizing effect as raising the ionic strength (Figure
2B), similar to the effect seen with ASF1A and H3 (Sup-
plementary Figure S1A). However, whilst ASF1A was ex-
cluded from the sNASP–H3 dimer (Figure 1G), upon sepa-
ration of the solubilized precipitate by gel filtration, we ob-
served co-elution of all four proteins, forming a sNASP–
H3–H4–ASF1A tetramer (Figure 2C). We could not detect
any interaction between sNASP and ASF1A in the absence
of H3 and H4 under the same conditions (Figure 2D), sug-
gesting that the interaction between sNASP and ASF1A is
mediated through their histone substrate.
Previously, we were unable to detect an interaction be-
tween the budding yeast homolog of sNASP, Hif1 and an
H3 116–135 peptide of H3 (25), even though the interac-
tion was detectable in a more evolutionary distant plant ho-
molog. We therefore wondered whether Hif1 was capable
of interacting with H3–H4 whilst in complex with ASF1,
as has been shown previously (23). To test this, we recon-
stituted the Hif1–H3–H4–ASF1A complex, and separated
out the components using gel filtration chromatography. As
the globular domain of human ASF1A and yeast Asf1, the
main interaction site between the histone chaperone and
H3–H4, is highly conserved we used the human ASF1A
in these experiments. However, it should be noted that the
yeast Asf1 has a longer acidic tail region compared to hu-
man ASF1A, that may carry functional importance. Inter-
estingly, Hif1 coeluted with H3, H4 and ASF1A (Figure
2E), suggesting that althoughHif1 is unable to interact with
the H3 C-terminal peptide with any significant affinity (25),
it has retained its ability to interact with anH3–H4 dimer in
the presence of ASF1A, as has recently been suggested (49).
These findings reveal that sNASP plays a crucial role in pre-
venting aggregation of the H3–H4–ASF1A complex, and
recapitulates previous in vivo findings showing that sNASP
forms a stable complex with ASF1 and histones through in-
teractions that are evolutionary conserved from yeast to hu-
mans.
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Figure 2. sNASP solubilises H3–H4–ASF1A by forming a stable sNASP–
H3–H4–ASF1A complex. (A) Salt titration showing the solubility of the
H3–H4–ASF1A complex is dependent on ionic strength. Soluble and in-
soluble material were separated by centrifugation before analysis by SDS-
PAGE PAGE and coomassie staining. (B) The precipitate formed at lower
ionic strength conditions in (A) (200 mM sodium chloride) can be solubi-
lized through titration of sNASP. At an equimolar ratio of sNASP to H3–
H4–ASF1A near complete solubilization is observed. (C) Gel filtration
elution profile of sNASP bound to the H3–H4–ASF1A complex showing
co-elution of all four proteins as visualized by SDS-PAGE and coomassie
staining. A molar excess of ASF1A over all other components was used
to gauge the stoichiometry of the complex. (D) Gel filtration elution pro-
file of sNASP and ASF1A showing that the two chaperones elute in sepa-
rate fractions, and therefore do not interact in the absence of their histone
cargo. (E) Elution profile of the yeast homolog of sNASP, Hif1, showing
that the complex formed between sNASP family of histone chaperones and
H3–H4–ASF1A is evolutionary conserved.
The TPR–H3 peptide interaction is not required for sNASP–
H3–H4–ASF1A complex formation
To reconcile the findings that sNASP and ASF1A bind
compatibly to an H3–H4 dimer whilst competing for the
same binding site on H3, we pursued the possibility that
either sNASP or ASF1A contain a secondary histone-
binding site in addition to those that have already been de-
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scribed. To determine which chaperonemay contain the pu-
tative secondary mode of binding, we used previously de-
fined point mutants of ASF1A (V94R) (31) and sNASP
(E246A/Y249S/L253S, termed EYL>ASS) (25) that dis-
rupt their known binding sites to histones: ASF1A V94R
mutates a key hydrophobic patch that interacts with the
H3 C-terminal region, whereas sNASP EYL>ASS mutates
residues within the H3 peptide-binding pocket formed by
the TPR repeat motifs. We hypothesized that a retained in-
teraction in the presence of a mutation would be indicative
of a secondary mode of binding. As the sub-components of
the sNASP–H3–H4–ASF1A complex are prone to aggre-
gation in vitro (Figure 2A) we initially employed the Fluo-
rescent 2-Hybrid (F2H) assay to probe the complex in live
cells. In the F2H assay a protein–protein interaction can be
observed by assessing the ability of a bait protein, tethered
to an integrated LacO array, to recruit a soluble prey pro-
tein fused to a fluorescent protein (Figure 3A) (35,36). Us-
ing this assay we found that an mCherry-LacI-sNASP bait
construct efficiently recruited a solublemEGFP-ASF1A fu-
sion construct to the LacO array, but that mEGFP-ASF1A
was not recruited to the empty mCherry-LacI fusion (Fig-
ure 3A–C). As sNASP and ASF1A do not interact directly
in vitro (Figure 2D), this interaction is most likely medi-
ated through endogenous H3–H4 present in the cell (as il-
lustrated in Figure 3A). Using the ASF1A V94R mutation
to disrupt histone binding, we abolished the recruitment of
ASF1A V94R to the sNASP-tethered array, whereas muta-
tion of the sNASP TPR–H3 peptide binding interface had
little effect on recruitment (Figure 3B and C), suggesting
that a secondary mode of binding exists between sNASP
and the H3–H4 dimer. These results are in agreement with
a previous study in which the V94R mutation of ASF1A
failed to pull down NASP from whole cell extracts (18). To
further test the idea of a secondary mode of interaction be-
tween sNASP and histones, and to exclude possible effects
from extraneous cellular components, we reconstituted the
sNASP–H3–H4–ASF1A complex in vitro using the sNASP
EYL>ASS mutant and found that it forms a complex with
H3–H4–ASF1A similar to wild-type sNASP (Figure 3D).
Taken together, these findings suggest that it is the sNASP
component of the sNASP–H3–H4–ASF1A complex which
contains a secondary, as yet uncharacterized, mode of his-
tone interaction, and that, unlike the TPR–H3 peptide in-
teraction (Figure 1E and F), this mode of interaction is
compatible with co-binding of ASF1A.
Generation of monobodies specific to sNASP
As a means to investigate the secondary mode of sNASP’s
interaction with H3–H4 further, we attempted to isolate
monobody binders to sNASP (Figure 4A–C). Monobod-
ies are synthetic, monoclonal binding proteins constructed
with the fibronectin type III scaffold that can be isolated
against specific antigens using various display technolo-
gies (37,50,51). They function as exquisite molecular probes
in studying protein–protein interactions (40,41,52,53). In
designing the sNASP antigen for monobody generation,
we removed the unstructured C-terminal region of sNASP
(residues 331–449), but retained the central acidic domain
that interrupts its TPR2 motif so as not to overtly con-
strain the folded core of the TPR domain (Figure 4A and
B), because we were interested in obtaining monobodies
directed to the structured regions of sNASP. The result-
ing sNASP N-330 construct retained its interaction with
the H3–H4–ASF1A complex (Supplementary Figure S2A),
and was used to screen a large monobody library to isolate
sNASP-specific binders (Figure 4C).
We identified two sNASP-specific monobodies termed
Mb(sNASP 1) and mbsNASP 13 (for brevity referred to as
mb1 andmb13; see Supplementary Figure S2B for sequence
information) that interacted with sNASP with nanomo-
lar affinity (Figure 4D), as measured by yeast display (37).
Binding of mb1 and mb13 to sNASP was further tested us-
ing full-length sNASP andmonobodies expressed and puri-
fied from bacteria. Upon recombinant expression, mb1 had
limited solubility on its own, and so was expressed as a mal-
tose binding protein (MBP) fusion, which also aided in re-
solving the two monobodies during SDS-PAGE. As mb1
and mb13 were isolated separately against a truncated form
of sNASP, we first addressed whether the two monobod-
ies interacted with full-length sNASP, and whether their
binding was mutually exclusive (representing overlapping
binding sites) or not (representing non-overlapping binding
sites). Mixing equimolar concentrations of sNASP, MBP-
mb1 and mb13 we observed that all three proteins eluted
in a single peak during gel filtration chromatography (Fig-
ure 4E, peak 1), confirming their interaction with full-
length sNASP, and demonstrating that they bind to non-
overlapping surfaces of sNASP. Next, we wanted to know
if we could further define the interaction sites of the mono-
bodies on the surface of sNASP. Previously, we demon-
strated that the central acidic domain of sNASP could be
removed, leaving a contiguous TPR (cTPR) construct that
retainedH3-peptide binding ability (25). To test whether the
acidic domainwas required for eithermb1 ormb13 binding,
we repeated the binding experiment using the cTPRmutant.
Interestingly, whilst mb13 binding was not affected, co-
eluting with sNASP (Figure 4F, peak 1), MBP-mb1 eluted
on its own in a separate fraction (Figure 4F, peak 2). This
suggests that the acidic domain of sNASP comprises at
least part of the binding epitope of mb1, whereas mb13
binds to another site on sNASP’s TPR domain. Therefore,
these monobodies represent unique probes for investigating
the involvement of different surfaces of sNASP in histone
recognition.
Surface mapping of sNASP reveal two additional histone in-
teraction sites required for sNASP–H3–H4–ASF1A complex
formation
As monobodies bind to discrete surface epitopes on their
target protein, we wanted to address whether the interac-
tion sites of mb1 and mb13 overlapped with any of the hi-
stone binding interfaces of sNASP. We first tested compat-
ibility of monobody binding with the H3 C-terminal pep-
tide (Figure 5A). Whilst mb13 remained largely associated
to sNASP in the presence of MBP–H3 (116–135), a sig-
nificant proportion of MBP-mb1 was displaced, eluting in
a separate peak (Figure 5A, peak 2). This suggests that
mb1 and H3 (116–135) have at least partially overlapping
binding sites, whereas mb13 binds to sNASP on the TPR
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domain/capping region (Figure 4F), but outside of the cen-
tral H3 peptide-binding channel. We next tested whether
binding of mb1 and mb13 is compatible with full-length
H3 interaction (Figure 5B). Surprisingly, although the epi-
tope of mb13 was outside of the H3 peptide-binding region,
mb13 was displaced from sNASP upon interaction with
H3. Mb1 was also displaced as expected, with the majority
of both monobodies eluting in their own fractions (peaks
2 and 3), whilst sNASP and H3 eluted as a single com-
plex (Peak 3) (Figure 5B). Finally, we addressed whether
mb1 and mb13 remain associated to sNASP whilst it is in
complex with H3–H4 and ASF1A (Figure 5C). Similar to
full-length H3, mb1 and mb13 were displaced upon bind-
ing of the H3–H4–ASF1A complex, eluting in their indi-
vidual fractions (peaks 2 and 3) when analyzed by gel fil-
tration chromatography, whereas sNASP eluted as a com-
plex with H3–H4–ASF1A (Peak 1) (Figure 5C). Consid-
ering the mapping of the monobody binding sites to two
discrete epitopes on the surface of sNASP (Figure 4E and
F), these findings suggest that sNASP makes extensive in-
teractions with both full-length H3 on its own, and with
an H3–H4 dimer in the context of the H3–H4–ASF1A
complex. This secondary mode of interaction involves at
least two additional interactions sites on sNASP: the acidic
domain that interrupts the two helices of the TPR2 mo-
tif, and the surface of the TPR domain or capping region
outside of the central peptide-binding cavity. In summary,
and in support of biochemical analysis of the sNASP–H3–
H4–ASF1A complex, surface mapping of sNASP using
our monobodies mb1 and mb13 has revealed that sNASP
makes an extensive interaction interface with both full-
length H3 and with the H3–H4–ASF1A complex, and that
the outer surface of TPR domain/capping region and the
central acidic domain constitute at least part of this inter-
face (for a summary of the monobody interactions see Fig-
ure 5D).
The acidic domain of sNASP is crucial for sNASP–H3–H4–
ASF1A complex formation
Next, we wanted to independently confirm the importance
of the secondary histone binding sites of sNASP identi-
fied by monobody surface mapping. Attempts to gain high-
resolution structural information on the mb1 and mb13-
sNASP complexes through co-crystalization have thus far
not succeeded, making the exact location of monobody
binding difficult to determine. However, as the mb1 binding
site can be disrupted by removing the acidic domain to form
a contiguous TPR domain (sNASP cTPR) (Figure 4F) (25),
and as mb1 is effectively displaced from sNASP byH3–H4–
ASF1A, we deduced that the acidic domain may represent
at least part of the sNASP binding interface with H3–H4–
ASF1A. Interestingly, whilst the position and overall acidic
nature of the domain is conserved amongst diverse species,
we could not identify any overriding sequence conserva-
tion outside of its enrichment in glutamate and aspartate
residues (Supplementary Figure S3). To further investigate
the role of the acidic domain in ASF1–H3–H4 binding, we
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mixed the cTPR mutant with H3–H4 and ASF1A at high
salt concentration (0.6 M sodium chloride) to prevent pre-
cipitation of the components (Figure 2A and B) and sepa-
rated out the formed complexes by gel filtration chromatog-
raphy (Figure 6A–C: ASF1A was kept at a molar excess
over the other components to judge the stoichiometry of
the complex and to serve as an internal control in marking
the elution point of free ASF1A). Interestingly, the sNASP
cTPRmutant failed to co-migrate with the H3–H4–ASF1A
complex, whereas the H3–H4–ASF1A complex eluted in
the bed volume of the column (Figure 6B and C). As the
H3–H4–ASF1A complex is aggregation-prone under phys-
iologically relevant salt concentrations used in the exper-
iment (Figure 2A), elution in the bed volume most likely
represents the complex being kept in solution by the higher
salt concentration used in sample preparation. It should
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be noted that the same conditions were used for success-
fully separating the entire sNASP–H3–H4–ASF1A com-
plex containing the sNASP N-330 truncation mutant (Sup-
plementary Figure S2A), showing that under these condi-
tion of high salt loading the sNASP–H3–H4–ASF1A com-
plex is still able to form normally. This finding suggests
that the acidic domain, although dispensable for binding the
H3 C-terminal peptide of H3 (25), is necessary for the sec-
ondary mode of interaction between sNASP and the H3–
H4 dimer whilst it is in complex with ASF1A, support-
ing our view that sNASP utilizes secondary histone-binding
sites.
sNASP and ASF1 cooperate to fold an H3–H4 dimer under
native conditions in vitro
As sNASP forms a stable complex with H3 in the absence
of H4 (Figure 1F), sNASP may work upstream of ASF1A
in the histone chaperoning pathway, scaffolding free H3
and aiding in its folding with H4 to form an sNASP–H3–
H4–ASF1A complex. If this were the case, we wondered
whether the sNASP–H3–H4–ASF1A complex could be re-
constituted using histone monomers as substrates, bypass-
ing the requirement for using pre-folded H3–H4 dimers
(Figure 7A). To test this, we mixed sNASP with monomeric
H3 and H4 (dissolved in water) and ASF1A, and analyzed
the resulting mixture by gel filtration chromatography (Fig-
ure 7B). Remarkably, we found that sNASP, H3, H4 and
ASF1A all eluted in a stable complex, comparable to that
seen when using pre-folded H3–H4 dimers to reconstitute
the complex (Figure 2C), in addition to a small quantity of
aggregates eluting in the void volume of the column (Figure
7B).
Whilst reconstituting the sNASP–H3–H4–ASF1A from
unfolded histones, we noticed that the order in which the
histones and chaperones were combined, greatly affected
the efficiency of reconstitution, with some orders of addi-
tion producing marked precipitation over others. We rea-
soned that some interactions may need to occur before oth-
ers in order to drive complex assembly. We investigated
this possibility by systematically combining the four com-
ponents (sNASP, H3, H4 and ASF1A) in all possible or-
ders of addition, and measured the reconstitution efficiency
by quantifying the precipitate formed (Figure 7C). Interest-
ingly, when we ranked the orders of addition according to
total relative precipitate, we see that in the top quartile of
most efficient reconstitutions, sNASP is always added be-
fore ASF1A. Conversely, we see that in the bottom quartile
(the least efficient reconstitutions), ASF1A is always added
before sNASP. This reveals a general rule in which efficient
reconstitution of the tetrameric complex in vitro requires
sNASP to be added before ASF1A. These results support
the idea that sNASP functions upstream of ASF1A in the
histone chaperoning pathway.
To test if the H3 and H4 are folded correctly with the
reconstituted sNASP–H3–H4–ASF1A complex, we carried
out a tetrasome reconstitution assay (42,45), with the view
that a correctly folded H3–H4 dimer should behave iden-
tically to a prefolded H3–H4 dimer in both its efficiency
of tetrasome reconstitution and its migration pattern dur-
ing native PAGE. In this assay, the ability of a chaperone
to mitigate aggregation and promote correct folding of a
tetrasome particle is assessed under increasing histone to
DNA ratios. At lower ratios, disomes are formed (a single
H3–H4 dimer associated with DNA), leading to tetrasome
formation (two H3–H4 dimers associated with DNA) and
then aggregation when histones are in a large excess, as has
been observed previously (42,44). Similarly, we see that both
sNASP and ASF1A can individually aid in depositing H3–
H4 onto DNA, with sNASP preferentially forming tetra-
somes and ASF1A preferentially forming disomes, whereas
traditional salt dialysis results in tetrasome formation (Sup-
plementary Figure S4). Furthermore, when sNASP and
ASF1A are combined, both disomes and tetrasomes are
formed with disomes predominating (Supplementary Fig-
ure S4).
Direct addition of pre-folded H3–H4 dimers to DNA re-
sults in poor assembly of tetrasomes, with increasing hi-
stone to DNA ratios resulting in aggregation (Figure 7E,
lanes 1–3). The addition of unfolded H3 and H4 results in
even poorer tetrasome reconstitution, as would be expected
(Figure 7E, lanes 4–6). However, when H3–H4 dimers are
first assembled in an sNASP–H3–H4–ASF1A complex be-
fore adding DNA, reconstitution is greatly enhanced (Fig-
ure 7E, lanes 7–9), as may be expected from the chap-
erones preventing non-productive thermodynamic traps,
thereby guidingmore efficient tetrasome reconstitution. Im-
portantly, however, there is no observable difference in ei-
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Figure 7. sNASP and ASF1A are capable of folding an H3–H4 dimer in vitro. (A) Flow chart showing the two different strategies for reconstituting the
sNASP–H3–H4–ASF1A complex in vitro. (B) H3 and H4 monomers dissolved in water were mixed with sNASP and ASF1A and the resulting complexes
separated by gel filtration chromatography. The positions of aggregates, sNASP–H3–H4–ASF1A complex and free ASF1A are shown. (C) Reconstituting
the sNASP–H3–H4–ASF1A complex. sNASP (N), ASF1A (A), H3 (3) and H4(4) were combined in all possible orders of addition and the soluble and
insoluble fractions isolated and analyzed by SDS-PAGE. (D) Quantification and ranking of the total relative precipitate (insoluble fraction) formed from
each order of addition shown in (C). The experiment was carried out in triplicate with the error representing the standard deviation. (E) Tetrasome
assembly assay comparing the sNASP–H3–H4–ASF1A complexes formed from either prefolded histones or unfolded histones. Positions of tetrasomes,
disomes and free DNA are shown. 0.5 M of DNA was combined with 1, 2 or 4 M of H3 & H4 (lanes 1–3), H3–H4 dimers (lanes 4–6) or sNASP–H3–
H4–ASF1A complex made from prefolded H3–H4 (lanes 7–9) or unfolded H3 & H4 (lanes 10–12), representing a 1:1, 1:2 and 1:4 molar ratio of DNA
to H3–H4 tetramer in each case. (F) A molecular model for the role of sNASP and ASF1 in H3–H4 chaperoning. The interaction between sNASP and
H3 is mediated by the TPR domain binding to the H3 C-terminus, and through additional contacts involving the acidic domain and an interaction site
on the TPR domain/capping region that lies outside of the central H3 peptide-binding channel. ASF1A cannot compete for H3 binding when it is bound
by sNASP. Folding with H4 causes a conformational change in H3, which results in a transition of the H3 C-terminal region from the TPR domain to its
position within the globular core of the histone fold. As ASF1 recognises the folded surface of an H3–H4 dimer, this transition is accompanied by ASF1
binding at the C-terminal region of H3. sNASP is retained within the H3–H4–ASF1 complex through its secondary modes of interaction with the H3–H4
dimer that are compatible with ASF1 binding. In complex with H3–H4–ASF1, sNASP contributes to the solubility of the histones and prevents their
aggregation.
Downloaded from https://academic.oup.com/nar/article-abstract/45/2/643/2953311/sNASP-and-ASF1A-function-through-both-competitive
by University of Warwick user
on 19 October 2017
654 Nucleic Acids Research, 2017, Vol. 45, No. 2
ther the efficiency of tetrasome reconstitution or the migra-
tion pattern of histone–DNA complexes when comparing
sNASP–H3–H4–ASF1A complex formed from pre-folded
H3–H4 dimers (Figure 7E, lanes 7–9) and sNASP–H3–H4|
ASF1A complex formed frommonomeric H3 and H4 (Fig-
ure 7E, lanes 10–12). This suggests that sNASP andASF1A
are fully capable of efficiently folding anH3–H4 dimer from
unfolded monomeric substrates in vitro and supports the
notion that sNASP functions upstream of ASF1A in the
histone chaperoning pathway.
DISCUSSION
sNASP represents a family of TPR motif containing chap-
erones that specifically interact with histones H3 and H4.
In vivo sNASP has been isolated in complex with other co-
chaperones, including ASF1A/B, RbAp46 and the histone
acetyl-transferase HAT1, which represents the major solu-
ble source of H3–H4 within the cell. Previously, we iden-
tified that the H3 binding site of sNASP overlaps signifi-
cantly with that of ASF1A (25), suggesting that (1) binding
site competition may be important in H3–H4 maturation,
and (2), as ASF1A and sNASP exist in complex with each
other, either sNASP or ASF1A contain secondary interac-
tion sites with their histone substrate.
In this current study, we have presented a detailed bio-
chemical investigation into how sNASP and ASF1A co-
chaperone histones H3 and H4, and present a model in
which sNASP andASF1A cooperate through both compet-
itive and compatible interactions to fold and retain an H3–
H4 dimer in an aggregation-resistant state (Figure 7F). In
this model, formation of a sNASP–H3 complex is upstream
of the sNASP–H3–H4–ASF1A complex. Importantly, in a
cellular context this is most likely also associated with the
HAT1-complex and other accessory factors (10,11,19,20).
Interaction between sNASP andH3 in the sNASP–H3 com-
plex is predominantly mediated by the high affinity TPR-
peptide interaction (25). However, displacement of both
mb1 and mb13 monobody probes also suggested that sec-
ondary modes of interaction between sNASP and H3 are
present, involving both the acidic domain and the outer sur-
face of the TPR domain/capping region (Figure 6B). In
contrast to sNASP, ASF1A mediates its interaction pre-
dominantly with the folded surface of the H3–H4 dimer
(30,32), agreeing with our observation that ASF1A is un-
able to compete with sNASP for binding of H3 in the ab-
sence of H4 (Figure 1C–G). Upon H3 folding with H4, se-
questration of residues important inmediating theTPR–H3
peptide interaction (Ala127,Arg131) (Figure 1A)within the
histone fold may act to reduce the grip of sNASP on this re-
gion and result in a transition from sNASP being bound at
the C-terminus of H3 to ASF1A being bound as the H3–
H4 dimer forms. sNASP, however, is still retained within
the ASF1–H3–H4 complex through its secondary interac-
tion sites involving the central acidic domain and the outer
surface of the TPR/capping region (Figures 5 and 6). Due
to their ability to solubilise the otherwise aggregation prone
ASF1–H3–H4 complex, these secondary modes of interac-
tion between sNASP and H3–H4 most likely aid in pre-
venting non-specific interactions within a cellular context,
ensuring that a soluble pool of histones is maintained at
all times. In this regard, the molecular model we propose
is consistent with findings showing that NASP contributes
to the fine-tuning of a soluble reservoir of H3–H4 through
inhibition of chaperone-mediated autophagy (CMA) (21).
Furthermore, as sNASP and ASF1A are sufficient for fold-
ing of an H3–H4 dimer in vitro, the isolation of protein
folding chaperones associated with histone H3 (17) may re-
late to a role of the these proteins in CMA/quality control,
rather than in generating an H3–H4 dimer.
Most biochemical analysis to date has involved individ-
ual analysis of histone chaperone function in isolation, this
being especially true for NASP (15,16,54,55). However, H3
and H4 are found in multi-chaperone complexes in the cell,
and so the individual function of each chaperone is likely
only to play an important but small role in the histone de-
position process. We have shown that sNASP has synergis-
tic functions with ASF1 towards H3 and H3–H4. Interest-
ingly, H4 has also been shown to have specific chaperones,
binding RbAp46 and HAT1, which form a stable dimeric
HAT1 complex, important in acetylation of lysine 5 and 12
of H4 (26,56,57). A recent crystal structure of the Saccha-
romyces cerevisiae homolog of the RbAp46–HAT1 dimer
bound to H4 and H3 peptides revealed that nearly half of
the H4 molecule is sequestered within the binding pockets
of the HAT1 complex (27), including the majority of the N-
terminal tail and the 1 helix of the histone core domain.
Interestingly, the 1 helix of H4 and the 3 helix of H3 re-
side in close proximity to each other on the same side of the
histone fold dimer. Binding and releasing of these regions
within the core histone fold domain may therefore aid in
guiding H3 and H4 down a productive folding pathway.
The role that sNASP plays in the folding, maturation and
storage of histones is complex and most likely involves a
number of other chaperones in addition to ASF1. In or-
der to further understand the process, high-resolution struc-
tures of the stable components of the pathway, namely
the sNASP–H3 dimer and the sNASP–H3–H4–ASF1A
tetramer, need to be solved and the dynamic intermediates
probed through complementary, biophysical means. The
role of additional factors, such as the HAT1 holo-enyme,
and how they function in concert with sNASP and ASF1
also has to be addressed. Importantly, novel approaches will
need to be developed in order to observe the rapid process
of ‘histone hand-off’ in vivo and to validate such mecha-
nisms, as we and others have proposed (17,21). In this re-
port, we have biochemically characterized the sNASP–H3
and sNASP–H3–H4–ASF1A complexes and demonstrated
that multiple interaction interfaces exist between sNASP
and histones. We have shown how these contend and coop-
erate with the chaperone ASF1A to form a folded H3–H4
dimer, establishing a mechanistic platform for the further
investigation of these dynamic histone chaperoning pro-
cesses.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
ACKNOWLEDGEMENTS
We would like to thank Gabriele Ludwig and Petra Heck-
meyer for technical help, members of the Ladurner and
Downloaded from https://academic.oup.com/nar/article-abstract/45/2/643/2953311/sNASP-and-ASF1A-function-through-both-competitive
by University of Warwick user
on 19 October 2017
Nucleic Acids Research, 2017, Vol. 45, No. 2 655
Koide groups for helpful discussions and Gyula Timinszky
for technical advice and discussions.
Author contributions: A.B. conceived of the project in dis-
cussion with A.G.L. and carried out the majority of the
experiments. A.K., J.S.G. and S.K. isolated and carried
out initial characterization of the monobodies. D.Z. con-
tributed to biochemical analysis of monobody interactions.
M.E.C. contributed to biochemical analysis of sNASP mu-
tants and their interaction with the ASF1–H3–H4 complex.
A.B. and A.G.L. wrote the manuscript with contributions
from S.K.
FUNDING
EMBO Long-term Fellowship [ALTF 887-2011 to A.B.];
Marie Curie Intra-European Fellowship for career devel-
opment [331726 FP7-PEOPLE-2012-IEF]; Wellcome Insti-
tutional Strategy Support Fund [WT105627MA]; Research
in the Ladurner laboratory is supported by the Bavar-
ian Research Network for Molecular Biosystems (BioSys-
Net); Deutsche Forschungsgemeinschaft; EUFP7Network
of Excellence ‘EpiGeneSys’; National Institutes of Health
[R01-DA036887]; University of Chicago Comprehensive
Cancer Center, NIH grant [P30-CA014599]. Funding for
open access charge: Deutsche Forschungsgemeinschaft.
Conflict of interest statement.A.K. and S.K. are listed as in-
ventors on a patent application filed by The University of
Chicago that covers a design of monobody libraries (United
States Patent application 13/813,409). The other authors
declare no competing financial interests.
REFERENCES
1. Gurard-Levin,Z.A., Quivy,J.P. and Almouzni,G. (2014) Histone
chaperones: assisting histone traffic and nucleosome dynamics. Annu.
Rev. Biochem., 83, 487–517.
2. Liu,W.H. and Churchill,M.E. (2012) Histone transfer among
chaperones. Biochem. Soc. Trans., 40, 357–363.
3. Das,C., Tyler,J.K. and Churchill,M.E.A. (2010) The histone shuffle:
histone chaperones in an energetic dance. Trends Biochem. Sci., 35,
476–489.
4. Burgess,R.J. and Zhang,Z. (2013) Histone chaperones in nucleosome
assembly and human disease. Nat. Struct. Mol. Biol., 20, 14–22.
5. Daniel Ricketts,M., Frederick,B., Hoff,H., Tang,Y., Schultz,D.C.,
Singh Rai,T., Grazia Vizioli,M., Adams,P.D. and Marmorstein,R.
(2015) Ubinuclein-1 confers histone H3.3-specific-binding by the
HIRA histone chaperone complex. Nat. Commun., 6, 7711.
6. Elsasser,S.J., Huang,H., Lewis,P.W., Chin,J.W., Allis,C.D. and
Patel,D.J. (2012) DAXX envelops an H3.3-H4 dimer for H3.3-specific
recognition. Nature, 491, 560–565.
7. Goldberg,A.D., Banaszynski,L.A., Noh,K.M., Lewis,P.W.,
Elsaesser,S.J., Stadler,S., Dewell,S., Law,M., Guo,X., Li,X. et al.
(2010) Distinct factors control histone variant H3.3 localization at
specific genomic regions. Cell, 140, 678–691.
8. Drane,P., Ouararhni,K., Depaux,A., Shuaib,M. and Hamiche,A.
(2010) The death-associated protein DAXX is a novel histone
chaperone involved in the replication-independent deposition of
H3.3. Genes Dev., 24, 1253–1265.
9. Foltman,M., Evrin,C., De Piccoli,G., Jones,R.C., Edmondson,R.D.,
Katou,Y., Nakato,R., Shirahige,K. and Labib,K. (2013) Eukaryotic
replisome components cooperate to process histones during
chromosome replication. Cell Rep., 3, 892–904.
10. Ask,K., Jasencakova,Z., Menard,P., Feng,Y., Almouzni,G. and
Groth,A. (2012) Codanin-1, mutated in the anaemic disease CDAI,
regulates Asf1 function in S-phase histone supply. EMBO J., 31,
2013–2023.
11. Groth,A., Corpet,A., Cook,A.J., Roche,D., Bartek,J., Lukas,J. and
Almouzni,G. (2007) Regulation of replication fork progression
through histone supply and demand. Science, 318, 1928–1931.
12. Richet,N., Liu,D., Legrand,P., Velours,C., Corpet,A., Gaubert,A.,
Bakail,M., Moal-Raisin,G., Guerois,R., Compper,C. et al. (2015)
Structural insight into how the human helicase subunit MCM2 may
act as a histone chaperone together with ASF1 at the replication fork.
Nucleic Acids Res., 43, 1905–1917.
13. Huang,H., Stromme,C.B., Saredi,G., Hodl,M., Strandsby,A.,
Gonzalez-Aguilera,C., Chen,S., Groth,A. and Patel,D.J. (2015) A
unique binding mode enables MCM2 to chaperone histones H3–H4
at replication forks. Nat. Struct. Mol. Biol., 22, 618–626.
14. Nabeel-Shah,S., Ashraf,K., Pearlman,R.E. and Fillingham,J. (2014)
Molecular evolution of NASP and conserved histone H3/H4
transport pathway. BMC Evol. Biol., 14, 139.
15. Wang,H., Ge,Z., Walsh,S.T. and Parthun,M.R. (2012) The human
histone chaperone sNASP interacts with linker and core histones
through distinct mechanisms. Nucleic Acids Res., 40, 660–669.
16. Wang,H., Walsh,S.T. and Parthun,M.R. (2008) Expanded binding
specificity of the human histone chaperone NASP. Nucleic Acids Res.,
36, 5763–5772.
17. Campos,E.I., Fillingham,J., Li,G., Zheng,H., Voigt,P., Kuo,W.H.,
Seepany,H., Gao,Z., Day,L.A., Greenblatt,J.F. et al. (2010) The
program for processing newly synthesized histones H3.1 and H4. Nat.
Struct. Mol. Biol., 17, 1343–1351.
18. Jasencakova,Z., Scharf,A.N., Ask,K., Corpet,A., Imhof,A.,
Almouzni,G. and Groth,A. (2010) Replication stress interferes with
histone recycling and predeposition marking of new histones.Mol.
Cell, 37, 736–743.
19. Groth,A., Ray-Gallet,D., Quivy,J.P., Lukas,J., Bartek,J. and
Almouzni,G. (2005) Human Asf1 regulates the flow of S phase
histones during replicational stress.Mol. Cell, 17, 301–311.
20. Tagami,H., Ray-Gallet,D., Almouzni,G. and Nakatani,Y. (2004)
Histone H3.1 and H3.3 complexes mediate nucleosome assembly
pathways dependent or independent of DNA synthesis. Cell, 116,
51–61.
21. Cook,A.J., Gurard-Levin,Z.A., Vassias,I. and Almouzni,G. (2011) A
specific function for the histone chaperone NASP to fine-tune a
reservoir of soluble H3–H4 in the histone supply chain.Mol. Cell, 44,
918–927.
22. Campos,E.I., Smits,A.H., Kang,Y.H., Landry,S., Escobar,T.M.,
Nayak,S., Ueberheide,B.M., Durocher,D., Vermeulen,M., Hurwitz,J.
et al. (2015) Analysis of the histone H3.1 interactome: a suitable
chaperone for the right event.Mol. Cell, 60, 697–709.
23. Fillingham,J., Recht,J., Silva,A.C., Suter,B., Emili,A., Stagljar,I.,
Krogan,N.J., Allis,C.D., Keogh,M.C. and Greenblatt,J.F. (2008)
Chaperone control of the activity and specificity of the histone H3
acetyltransferase Rtt109.Mol. Cell. Biol., 28, 4342–4353.
24. Garg,J., Lambert,J.P., Karsou,A., Marquez,S., Nabeel-Shah,S.,
Bertucci,V., Retnasothie,D.V., Radovani,E., Pawson,T., Gingras,A.C.
et al. (2013) Conserved Asf1-importin beta physical interaction in
growth and sexual development in the ciliate Tetrahymena
thermophila. J. Proteomics, 94, 311–326.
25. Bowman,A., Lercher,L., Singh,H.R., Zinne,D., Timinszky,G.,
Carlomagno,T. and Ladurner,A.G. (2016) The histone chaperone
sNASP binds a conserved peptide motif within the globular core of
histone H3 through its TPR repeats. Nucleic Acids Res., 44,
3105–3117.
26. Murzina,N.V., Pei,X.Y., Zhang,W., Sparkes,M., Vicente-Garcia,J.,
Pratap,J.V., McLaughlin,S.H., Ben-Shahar,T.R., Verreault,A.,
Luisi,B.F. et al. (2008) Structural basis for the recognition of histone
H4 by the histone-chaperone RbAp46. Structure, 16, 1077–1085.
27. Li,Y., Zhang,L., Liu,T., Chai,C., Fang,Q., Wu,H., Agudelo
Garcia,P.A., Han,Z., Zong,S., Yu,Y. et al. (2014) Hat2p recognizes
the histone H3 tail to specify the acetylation of the newly synthesized
H3/H4 heterodimer by the Hat1p/Hat2p complex. Genes Dev., 28,
1217–1227.
28. Song,J.J., Garlick,J.D. and Kingston,R.E. (2008) Structural basis of
histone H4 recognition by p55. Genes Dev., 22, 1313–1318.
29. Nowak,A.J., Alfieri,C., Stirnimann,C.U., Rybin,V., Baudin,F.,
Ly-Hartig,N., Lindner,D. and Muller,C.W. (2011)
Chromatin-modifying complex component Nurf55/p55 associates
with histones H3 and H4 and polycomb repressive complex 2 subunit
Downloaded from https://academic.oup.com/nar/article-abstract/45/2/643/2953311/sNASP-and-ASF1A-function-through-both-competitive
by University of Warwick user
on 19 October 2017
656 Nucleic Acids Research, 2017, Vol. 45, No. 2
Su(z)12 through partially overlapping binding sites. J. Biol. Chem.,
286, 23388–23396.
30. English,C.M., Adkins,M.W., Carson,J.J., Churchill,M.E.A. and
Tyler,J.K. (2006) Structural basis for the histone chaperone activity of
Asf1. Cell, 127, 495–508.
31. Mousson,F., Lautrette,A., Thuret,J.Y., Agez,M., Courbeyrette,R.,
Amigues,B., Becker,E., Neumann,J.M., Guerois,R., Mann,C. et al.
(2005) Structural basis for the interaction of Asf1 with histone H3
and its functional implications. Proc. Natl. Acad. Sci. U.S.A., 102,
5975–5980.
32. Natsume,R., Eitoku,M., Akai,Y., Sano,N., Horikoshi,M. and
Senda,T. (2007) Structure and function of the histone chaperone
CIA/ASF1 complexed with histones H3 and H4. Nature, 446,
338–341.
33. Luger,K., Rechsteiner,T.J., Flaus,A.J., Waye,M.M.Y. and
Richmond,T.J. (1997) Characterization of nucleosome core particles
containing histone proteins made in bacteria. J. Mol. Biol., 272,
301–311.
34. Czarna,A., Berndt,A., Singh,H.R., Grudziecki,A., Ladurner,A.G.,
Timinszky,G., Kramer,A. and Wolf,E. (2013) Structures of
Drosophila cryptochrome and mouse cryptochrome1 provide insight
into circadian function. Cell, 153, 1394–1405.
35. Zolghadr,K., Mortusewicz,O., Rothbauer,U., Kleinhans,R.,
Goehler,H., Wanker,E.E., Cardoso,M.C. and Leonhardt,H. (2008) A
fluorescent two-hybrid assay for direct visualization of protein
interactions in living cells.Mol. Cell. Proteomics : MCP, 7,
2279–2287.
36. Zolghadr,K., Rothbauer,U. and Leonhardt,H. (2012) The fluorescent
two-hybrid (F2H) assay for direct analysis of protein–protein
interactions in living cells.Methods Mol. Biol., 812, 275–282.
37. Koide,A., Wojcik,J., Gilbreth,R.N., Hoey,R.J. and Koide,S. (2012)
Teaching an old scaffold new tricks: monobodies constructed using
alternative surfaces of the FN3 scaffold. J. Mol. Biol., 415, 393–405.
38. Koide,A., Wojcik,J., Gilbreth,R.N., Reichel,A., Piehler,J. and
Koide,S. (2009) Accelerating phage-display library selection by
reversible and site-specific biotinylation. Protein Eng. Des. Sel.:
PEDS, 22, 685–690.
39. Koide,S., Koide,A. and Lipovsek,D. (2012) Target-binding proteins
based on the 10th human fibronectin type III domain ((1)(0)Fn3).
Methods Enzymol., 503, 135–156.
40. Stockbridge,R.B., Koide,A., Miller,C. and Koide,S. (2014) Proof of
dual-topology architecture of Fluc F- channels with monobody
blockers. Nat. Commun., 5, 5120.
41. Tanaka,S., Takahashi,T., Koide,A., Ishihara,S., Koikeda,S. and
Koide,S. (2015) Monobody-mediated alteration of enzyme specificity.
Nat. Chem. Biol., 11, 762–764.
42. Scorgie,J.K., Donham,D.C. 3rd and Churchill,M.E. (2012) Analysis
of histone chaperone antisilencing function 1 interactions.Methods
Enzymol., 512, 223–241.
43. Liu,W.H., Roemer,S.C., Port,A.M. and Churchill,M.E. (2012)
CAF-1-induced oligomerization of histones H3/H4 and mutually
exclusive interactions with Asf1 guide H3/H4 transitions among
histone chaperones and DNA. Nucleic Acids Res., 40, 11229–11239.
44. Donham,D.C. 2nd, Scorgie,J.K. and Churchill,M.E. (2011) The
activity of the histone chaperone yeast Asf1 in the assembly and
disassembly of histone H3/H4-DNA complexes. Nucleic Acids Res.,
39, 5449–5458.
45. Bowman,A., Ward,R., Wiechens,N., Singh,V., El-Mkami,H.,
Norman,D.G. and Owen-Hughes,T. (2011) The histone chaperones
Nap1 and Vps75 bind histones H3 and H4 in a tetrameric
conformation.Mol. Cell, 41, 398–408.
46. Thastrom,A., Lowary,P.T., Widlund,H.R., Cao,H., Kubista,M. and
Widom,J. (1999) Sequence motifs and free energies of selected natural
and non-natural nucleosome positioning DNA sequences. J. Mol.
Biol., 288, 213–229.
47. Lowary,P.T. and Widom,J. (1998) New DNA sequence rules for high
affinity binding to histone octamer and sequence-directed
nucleosome positioning. J. Mol. Biol., 276, 19–42.
48. English,C.M., Maluf,N.K., Tripet,B., Churchill,M.E.A. and
Tyler,J.K. (2005) ASF1 binds to a heterodimer of histones H3 and
H4: A two-step mechanism for the assembly of the H3–H4
heterotetramer on DNA. Biochemistry, 44, 13673–13682.
49. Haigney,A., Ricketts,M.D. and Marmorstein,R. (2015) Dissecting
the molecular roles of histone chaperones in histone acetylation by
type B histone acetyltransferases (HAT-B). J. Biol. Chem., 290,
30648–30657.
50. Richards,J., Miller,M., Abend,J., Koide,A., Koide,S. and Dewhurst,S.
(2003) Engineered fibronectin type III domain with a RGDWXE
sequence binds with enhanced affinity and specificity to human
alphavbeta3 integrin. J. Mol. Biol., 326, 1475–1488.
51. Koide,A., Bailey,C.W., Huang,X. and Koide,S. (1998) The
fibronectin type III domain as a scaffold for novel binding proteins. J.
Mol. Biol., 284, 1141–1151.
52. Sha,F., Gencer,E.B., Georgeon,S., Koide,A., Yasui,N., Koide,S. and
Hantschel,O. (2013) Dissection of the BCR-ABL signaling network
using highly specific monobody inhibitors to the SHP2 SH2 domains.
Proc. Natl. Acad. Sci. U.S.A., 110, 14924–14929.
53. Gilbreth,R.N., Truong,K., Madu,I., Koide,A., Wojcik,J.B., Li,N.S.,
Piccirilli,J.A., Chen,Y. and Koide,S. (2011) Isoform-specific
monobody inhibitors of small ubiquitin-related modifiers engineered
using structure-guided library design. Proc. Natl. Acad. Sci. U.S.A.,
108, 7751–7756.
54. Kato,D., Osakabe,A., Tachiwana,H., Tanaka,H. and Kurumizaka,H.
(2015) Human tNASP promotes in vitro nucleosome assembly with
histone H3.3. Biochemistry, 54, 1171–1179.
55. Finn,R.M., Browne,K., Hodgson,K.C. and Ausio,J. (2008) sNASP, a
histone H1-specific eukaryotic chaperone dimer that facilitates
chromatin assembly. Biophys J., 95, 1314–1325.
56. Verreault,A., Kaufman,P.D., Kobayashi,R. and Stillman,B. (1998)
Nucleosomal DNA regulates the core-histone-binding subunit of the
human Hat1 acetyltransferase. Curr. Biol., 8, 96–108.
57. Wu,H., Moshkina,N., Min,J., Zeng,H., Joshua,J., Zhou,M.M. and
Plotnikov,A.N. (2012) Structural basis for substrate specificity and
catalysis of human histone acetyltransferase 1. Proc. Natl. Acad. Sci.
U.S.A., 109, 8925–8930.
Downloaded from https://academic.oup.com/nar/article-abstract/45/2/643/2953311/sNASP-and-ASF1A-function-through-both-competitive
by University of Warwick user
on 19 October 2017
